Collectively, these findings suggest that hepatitis viruses promote insulin resistance and type 2 diabetes mellitus (T2DM) through STAT3-dependent mechanisms, including IRS functional inhibition, ubiquitin-mediated degradation, and metabolic reprogramming (Figure 1). This evidence concerns the gene STAT3 and Insulin resistance.